A novel small-molecule MRCK inhibitor blocks cancer cell invasion. (2014)
Attributed to:
Development of a novel drug targeting MRCK and ROCKII for the treatment of invasive and/or metastatic cancer.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12964-014-0054-x
PubMed Identifier: 25288205
Publication URI: http://europepmc.org/abstract/MED/25288205
Type: Journal Article/Review
Volume: 12
Parent Publication: Cell communication and signaling : CCS
ISSN: 1478-811X